Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter phase II trial designed to determine efficacy and safety
of a brief chemoimmunotherapy with the combination of Rituximab + Bendamustine + Mitoxantrone
in elderly patients with advanced stage Follicular Lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione Italiana Linfomi ONLUS
Collaborator:
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte